Abstract | BACKGROUND: METHODS: After randomization, 10 patients received a nerve stimulator-guided injection with methylprednisolone/ lidocaine, and 10 patients received saline. The primary outcome measure was pain (visual analogue scale, VAS). RESULTS: In the placebo group, there was a significant pain reduction (baseline VAS, 6.8; VAS week 12, 4.3; P = .014). The VAS score in the methylprednisolone group did not show a significant reduction (baseline VAS, 7.4; VAS week 12, 4.8; P = .053). There was no significant difference in pain reduction between the groups. CONCLUSIONS: We found no objective evidence for benefit from nerve stimulator-guided injection with corticosteroids in meralgia paresthetica, although this study is limited by a small sample size. Future placebo-controlled studies using ultrasound-guided injection are warranted.
|
Authors | Mark E Kloosterziel, Dénes L J Tavy, Samuel Arends, Joyce M Zijdewind, Erik W van Zwet, Paul W Wirtz |
Journal | Muscle & nerve
(Muscle Nerve)
Vol. 61
Issue 6
Pg. 788-791
(06 2020)
ISSN: 1097-4598 [Electronic] United States |
PMID | 32239737
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Copyright | © 2020 Wiley Periodicals, Inc. |
Chemical References |
- Anesthetics, Local
- Anti-Inflammatory Agents
- Lidocaine
- Methylprednisolone
|
Topics |
- Aged
- Anesthetics, Local
(administration & dosage)
- Anti-Inflammatory Agents
(administration & dosage)
- Double-Blind Method
- Drug Therapy, Combination
- Electric Stimulation
(methods)
- Female
- Femoral Nerve
(drug effects, physiology)
- Femoral Neuropathy
(diagnosis, drug therapy, physiopathology)
- Humans
- Injections
- Lidocaine
(administration & dosage)
- Male
- Methylprednisolone
(administration & dosage)
- Middle Aged
- Pain Measurement
(methods)
|